Pharmacokinetic study on pradofloxacin in the dog - Comparison of serum analysis, ultrafiltration and tissue sampling after oral administration

BMC Veterinary Research

Volumn 9, Issue , 2013, Pages

  Hauschild, Gregor ^a,d   Rohn, Karl ^b   Engelhardt, Eva ^c   Sager, Martin ^c   Hardes, Jendrik ^a   Gosheger, Georg ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d LESIA Center for Veterinary Medicine   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); CANIS FAMILIARIS; FELIDAE; POSIBACTERIA;

ANTIINFECTIVE AGENT; ENROFLOXACIN; PRADOFLOXACIN; QUINOLONE DERIVATIVE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CHEMISTRY; COMPARATIVE STUDY; DOG; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY; LIVER; METABOLISM; ORAL DRUG ADMINISTRATION; TISSUE DISTRIBUTION; ULTRAFILTRATION;

ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOGS; FEMALE; FLUOROQUINOLONES; KIDNEY; LIVER; TISSUE DISTRIBUTION; ULTRAFILTRATION;

MLCS; MLOWN;

EID: 84873592631     PISSN: None     EISSN: 17466148     Source Type: Journal    
DOI: 10.1186/1746-6148-9-32     Document Type: Article

References (34)

1. Silley P, Stephan B, Greife HA, Pridmore A. Comparative activity of pradofloxacin against anaerobic bacteria isolated from dogs and cats. J Antimicrob Chemother 2007, 60:999-1003. 10.1093/jac/dkm346, 17872918.
2. Blondeau JM. A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new respiratory quinolones. J Antimicrob Chemother 1999, 43(B):1-11.
3. Hawkey PM. Mechanisms of quinolone action and microbial response. J Antimicrob Chemother 2003, 51(S1):29-35.
4. Stephan B, Greife HA, Pridmore A, Silley P. Activity of pradofloxacin against porphyromonas and prevotella spp. implicated in periodontal disease in dogs: susceptibility test data from a European multicenter study. Antimicrobial Agents 2008, 52(6):2149-2155.
5. Liu P, Müller M, Dardendorf H. Rational dosing of antibiotics: the use of plasma concentrations versus tissue concentrations. Int J Antimicrob Agents 2002, 19:285-290. 10.1016/S0924-8579(02)00024-9, 11978499.
6. Müller M, Haag O, Burgdorff T, Georgopoulos A, Weninger W, Jansen B, Stanek G, Pehamberger H, Agneter E, Eichler HG. Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans. Antimicrob Agents Chemother 1996, 40:2703-2709. 163607, 9124826.
7. Müller M, Staß H, Brunner M, Möller JG, Lackner EU, Eichler HB. Penetration of moxifloxacin into peripheral compartements in humans. Antimicrob Agents Chemother 1999, 43:2345-2349. 89480, 10508004.
8. Bidgood TL, Papich MG. Plasma and interstitial fluid pharmacokinetics of enrofloxacin, its metabolite ciprofloxacin, and marbofloxacin after oral administration and a constant rate intravenous infusion in dogs. J Vet Pharmacol Ther 2005, 28:329-341. 10.1111/j.1365-2885.2005.00664.x, 16050812.
9. Krebber R. Analytical Method for the determination of pradofloxacin in serum and urine by turbulent flow chromatography/tandem mass spectrometry. J Vet Pharmacol Ther 2003, 26(1):102-103.
10. Krebber R, Hoffend F-J, Ruttmann F. Simple and Rapid Determination of Enrofloxacin and Ciprofloxacin in Edible Tissues by Turbulent Flow Chromatography/Tandem Mass Spectrometry (TFC-MS/MS) 2008, The Netherlands: Poster P187, EuroResidue VI, Egmond aan Zee.
11. Krebber R, Hoffend FJ. Determination of Pradofloxacin in Canine Skin Biopsies by HPLC-Tandem Mass Spectrometry 2004, Ottawa, Canada: Poster, 2nd International Conference on Antimicrobial Agents in Veterinary Medicine (AAVM).
12. Schink AK, Kadlec K, Hauschild T, Brenner Michael G, Dörner JC, Ludwig C, Werckenthin C, Hehnen H-R, Stephan B, Schwarz S. Susceptibility of canine and feline bacterial pathogens to pradofloxacin and comparison with other fluoroquinolones approved for companion animals. Vet Microbiol 2013, 162:116-126.
13. de la Pena A, Liu P, Derendorf H. Microdialysis in peripheral tissues. Adv Drug Deliv Rev 2000, 45:189-216. 10.1016/S0169-409X(00)00106-X, 11108974.
14. Wetzstein HG. In vitro postantibiotic effects of pradofloxacin in escherichia coli and staphylococcus aureus are greatly exceeded at sub-MIC drug concentrations. Abstr Intersci Conf Antimicrob Agents Chemother Intersci Conf Antimicrob Agents Chemother 2003, 43. abstract no. F-421 15.
15. Andes D, Craig WA. Animal model pharmacokinetics and pharmacodynamics: a critical review. Int J Antimicrob Agents 2002, 19:261-268. 10.1016/S0924-8579(02)00022-5, 11978497.
16. Boothe DM. The accumulation of pradofloxacin in phagocytes 2006, Berlin: First International Veraflox® Symposium. Abstracts, 18, March 16th to 19th.
17. Mensinger S. Pharmakokinetik und Pharmakodynamik von Pradofloxacin in einem " Tissue-Cage" -Modell beim Hund 2009, Justus-Liebig-Universität Giessen, Dissertation.
18. Janle-Swain E, Van Vleet JF, Ash SR. Use of a capillary filtrate collector for monitoring glucose in diabetics. ASAIO Trans 1987, 33(3):336-340.
19. Ogren S, Cars O. Importance of drug-protein interactions and protein concentrations for antibiotic levels in serum and tissue fluid. Scand J Infect Dis Supplement 1985, 44:34-40.
20. Frazier DL, Thompson L, Trettien A, Evans EI. Comparison of fluoroquinolone pharmacokinetic parameters after treatment wit marbofloxacin, enrofloxacin, and difloxacin in dogs. J Vet Pharmacol Ther 2000, 23:293-302. 10.1046/j.1365-2885.2000.00285.x, 11107003.
21. Silley P, Stephan B, Greife HA, Pridmore A. Post-Antibiotic Effect (PAE), Post-Antibiotic Sub-MIC Effect (PA SME) and Sub-MIC Effect (SME) of Pradofloxacin against Veterinary Isolates 2006, Orlando: Poster Z031, 106th Annual General Meeting, American Society for Microbiology.
22. Toutain PL. PK/PD approach for antibiotics: tissue or blood drug levels to predict antibiotic efficacy. J Vet Pharmacol Ther 2009, 32(Suppl. 1):19-21.
23. Gunderson BW, Ross GH, Ibrahim KH, Rotschafer JC. What do we really know about antibiotic pharmacodynamics?. Pharmacotherapy 2001, 21:302S-318S. 10.1592/phco.21.18.302S.33905, 11714222.
24. McKellar QA, Sanchez Bruni SF, Jones DG. Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine. J Vet Pharmacol Ther 2004, 27:503-514. 10.1111/j.1365-2885.2004.00603.x, 15601444.
25. Fraatz K, Heinen K, Krebber R, Edingloch M, Heinen E. Serum pharamcokinetics of pradofloxacin in dogs after multiple oral administration at various dosages 2002, American Society of Microbiology, San Diego, C.A: Abstract F-570. Abstracts of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy.
26. Bregante MA, de Jong A, Calvo A, Hernandez E, Rey R, Garcia MA. Protein binding of pradofloxacin, a, novel 8-cyanofluoroquinolone, in dog and cat plasma. J Vet Pharmacol Ther 2003, 26(Suppl. 1):87-88.
27. Mouton JW, Dudley MN, Cars O, Derendorf H, Drusano GL. Standardization of pharmacokinetic/pharmacodynamics (PK/PD) terminology for anti-infective drugs: an update. J Antimicrob Chemother 2005, 55:601-607. 10.1093/jac/dki079, 15772142.
28. Messenger KM, Papich MG, Blikslager AT. Distribution of enrofloxacin and its active metabolite, using an in vivo ultrafiltration sampling technique after injection of enrofloxacin in pigs. J Vet Pharmacol Ther 2012, 35:452-459. 10.1111/j.1365-2885.2011.01338.x, 21913941.
29. Brunner M, Langer O. Microdialysis versus other techniques for the clinical assessment of in vivo tissue drug distribution. AAPS J 2006, 8(2):E263-271. Article 30 (http://www.aapsj.org), 3231569, 16796376.
30. Cars O. Pharmacokinetics of antibiotics in tissues and tissue fluid: a review. Scand J Infect Dis Supplement 1991, 44:7-15.
31. Müller M, dela Pena A, Derendorf H. Issues in pharmacokinetics and pharmacodynamics of anti-infecitve agents: distribution in tissue. Antimicrob Agents Chemother 2004, 48:1441-1453. 10.1128/AAC.48.5.1441-1453.2004, 400530, 15105091.
32. Deterding LJ, Dix K, Burka LT, Tomer KB. On-line coupling of in vivo microdialysis with tandem mass spectrometry. Anal Chem 1992, 64(21):2636-2641. 10.1021/ac00045a029, 1443626.
33. Linhares MC, Kissinger PT. Pharmacokinetic monitoring in subcutaneous tissue unsing in vivo capillary ultrafiltration probes. Pharm Res 1993, 10:2831-2835.
34. Leegsma-Vogt G, Janle E, Ash S, Venema K, Korf J. Utilization of in vivo ultrafiltration in biomedical research and clinical application. Life Sci 2003, 73:2005-2018. 10.1016/S0024-3205(03)00569-1, 12899925.